LCP
BLUE

Lamond Capital Partners’s bluebird bio BLUE Stock Holding History

Lamond Capital Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,378
Closed -$13.5M – 13
2014
Q4 		$13.5M Buy
+11,378
New +$7.6M 8.85% 3

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Lamond Capital Partners's BLUE Position: Q1 2015 in Review

Lamond Capital Partners sold out of bluebird bio (BLUE) in Q1 2015, closing a stake of 11,378 shares — an estimated $13.5M sold.

Lamond Capital Partners first reported a position in BLUE in Q4 2014 and held it in 1 quarter. The position peaked at $13.5M in Q4 2014. 210 funds tracked by Wall St. Rank hold BLUE as of Q1 2015.

  • Lamond Capital Partners reported no remaining bluebird bio position as of Q1 2015 after selling out during the quarter.
  • Lamond Capital Partners sold 11,378 bluebird bio shares in Q1 2015, an estimated $13.5M.
  • Lamond Capital Partners first reported a position in bluebird bio in Q4 2014 and held it in 1 quarter.
  • Lamond Capital Partners's bluebird bio position peaked at $13.5M in Q4 2014.
  • 210 funds tracked by Wall St. Rank held bluebird bio as of Q1 2015.

Based on Lamond Capital Partners's 13F filing for Q1 2015, filed 12 May 2015.